-
Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald
Source: Buzz FX / 26 Feb 2025 09:41:20 America/New_York
Ultragenyx Pharmaceutical (NASDAQ:RARE) Receives Overweight Rating from Cantor Fitzgerald Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Ultragenyx Pharmaceutical ( NASDAQ:RARE - Get Free Report ) 's stock had its "
Read more...